Share Price and Basic Stock Data
Last Updated: December 13, 2025, 8:49 am
| PEG Ratio | -10.43 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Relaxo Footwears Ltd operates in the competitive footwear sector, and its recent financial performance underscores its resilience. For the fiscal year ending March 2024, the company reported sales of ₹2,914 Cr, a modest increase from ₹2,783 Cr in the previous year. However, this growth trajectory has not been linear; sales showed fluctuations over the quarters, peaking at ₹765 Cr in March 2023 before witnessing a dip to ₹715 Cr in September 2023. Such volatility reflects seasonal demand patterns in the footwear industry, which can be sensitive to changing consumer preferences and economic conditions. Despite this, Relaxo’s ability to maintain a revenue stream of ₹2,696 Cr in the trailing twelve months (TTM) indicates a stable core business, supported by a diverse product portfolio that includes popular brands like Relaxo and Sparx. The market capitalization of ₹10,014 Cr positions the company well among its peers, suggesting a solid foothold in the industry.
Profitability and Efficiency Metrics
The profitability metrics of Relaxo Footwears reveal a mixed performance. The operating profit margin (OPM) stood at 14% for FY 2025, reflecting a decline from the previous year’s 16%. This dip raises questions about cost management and pricing strategies in an inflationary environment. The net profit for FY 2025 was reported at ₹170 Cr, which is a decline from ₹200 Cr in FY 2024. Additionally, the return on equity (ROE) was recorded at 8.31%, which is relatively low compared to industry standards, indicating that the company may not be leveraging its equity efficiently. On the efficiency front, the cash conversion cycle (CCC) at 155 days suggests that it takes a considerable amount of time for the company to convert its investments in inventory and receivables back into cash. This could impact liquidity, especially in a sector where cash flow management is crucial.
Balance Sheet Strength and Financial Ratios
Relaxo Footwears maintains a robust balance sheet, characterized by low borrowings of just ₹215 Cr against total assets of ₹2,762 Cr. This translates to a debt-to-equity ratio that remains virtually negligible, indicating a strong capital structure. The company’s reserves have grown to ₹2,085 Cr, showcasing a commitment to retaining earnings for future growth. The interest coverage ratio (ICR) of 19.79x highlights Relaxo’s ability to comfortably meet its interest obligations, reflecting strong financial health. However, the price-to-book value (P/BV) ratio of 4.83x might seem stretched, suggesting that investors are paying a premium for the stock relative to its book value. This could be a double-edged sword; while it indicates investor confidence, it also means that any negative news could disproportionately impact the stock price.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Relaxo Footwears demonstrates a stable commitment from promoters, who hold 71.27% of the equity. This strong promoter holding can be reassuring for investors, indicating that the management has significant skin in the game. On the institutional front, foreign institutional investors (FIIs) hold approximately 3.04%, while domestic institutional investors (DIIs) account for 9.88%. This relatively low institutional ownership could suggest that the stock is perceived as a smaller player in a larger market, which might limit the stock’s liquidity. Notably, the number of public shareholders has decreased from 3,61,927 in December 2022 to 2,39,270 by September 2025, which could indicate a shift in investor sentiment or confidence. As the company navigates its growth trajectory, maintaining investor confidence will be key, especially in a sector that can be heavily influenced by consumer trends.
Outlook, Risks, and Final Insight
Looking ahead, Relaxo Footwears faces both opportunities and challenges. The company’s strong brand presence and market share in India can be leveraged for growth, particularly in the expanding e-commerce space. However, the fluctuating sales figures and declining profitability margins suggest that management must address operational efficiencies and cost structures to sustain growth. Risks also loom from economic uncertainties and changing consumer preferences, which can significantly affect demand. Investors should remain cautious, aware that while the strong balance sheet offers some comfort, the high P/BV ratio and declining profitability metrics warrant scrutiny. Overall, Relaxo Footwears presents a mixed bag for investors. The company’s established brand and financial stability may attract long-term investors, but potential volatility in earnings and market dynamics necessitates careful consideration before making investment decisions.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Campus Activewear Ltd | 8,046 Cr. | 263 | 338/210 | 65.0 | 26.0 | 0.38 % | 20.1 % | 17.2 % | 5.00 |
| AKI India Ltd | 75.3 Cr. | 7.30 | 16.3/6.56 | 38.0 | 8.35 | 0.00 % | 4.54 % | 1.80 % | 2.00 |
| Relaxo Footwears Ltd | 10,083 Cr. | 405 | 665/375 | 57.8 | 84.7 | 0.74 % | 11.2 % | 8.31 % | 1.00 |
| Liberty Shoes Ltd | 477 Cr. | 280 | 563/273 | 35.8 | 134 | 0.00 % | 9.99 % | 7.20 % | 10.0 |
| Khadim India Ltd | 315 Cr. | 171 | 330/169 | 21.9 | 90.2 | 0.00 % | 9.34 % | 2.20 % | 10.0 |
| Industry Average | 6,252.60 Cr | 347.72 | 47.48 | 77.04 | 0.52% | 11.71% | 8.72% | 5.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 667 | 670 | 681 | 765 | 739 | 715 | 713 | 747 | 748 | 679 | 667 | 695 | 654 |
| Expenses | 581 | 610 | 609 | 647 | 631 | 624 | 626 | 627 | 649 | 592 | 584 | 583 | 555 |
| Operating Profit | 86 | 59 | 72 | 118 | 108 | 92 | 87 | 120 | 99 | 88 | 83 | 112 | 99 |
| OPM % | 13% | 9% | 11% | 15% | 15% | 13% | 12% | 16% | 13% | 13% | 12% | 16% | 15% |
| Other Income | 4 | 6 | 4 | 4 | 7 | 11 | 6 | 5 | 5 | 7 | 7 | 8 | 11 |
| Interest | 7 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Depreciation | 30 | 31 | 32 | 33 | 35 | 37 | 38 | 38 | 39 | 40 | 40 | 39 | 40 |
| Profit before tax | 54 | 30 | 41 | 85 | 76 | 60 | 51 | 82 | 60 | 50 | 45 | 75 | 66 |
| Tax % | 28% | 26% | 26% | 26% | 26% | 27% | 24% | 25% | 26% | 26% | 26% | 25% | 26% |
| Net Profit | 39 | 22 | 30 | 63 | 56 | 44 | 39 | 61 | 44 | 37 | 33 | 56 | 49 |
| EPS in Rs | 1.55 | 0.90 | 1.21 | 2.54 | 2.26 | 1.78 | 1.55 | 2.47 | 1.78 | 1.48 | 1.33 | 2.26 | 1.96 |
Last Updated: August 1, 2025, 1:20 pm
Below is a detailed analysis of the quarterly data for Relaxo Footwears Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 654.00 Cr.. The value appears to be declining and may need further review. It has decreased from 695.00 Cr. (Mar 2025) to 654.00 Cr., marking a decrease of 41.00 Cr..
- For Expenses, as of Jun 2025, the value is 555.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 583.00 Cr. (Mar 2025) to 555.00 Cr., marking a decrease of 28.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 99.00 Cr.. The value appears to be declining and may need further review. It has decreased from 112.00 Cr. (Mar 2025) to 99.00 Cr., marking a decrease of 13.00 Cr..
- For OPM %, as of Jun 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 15.00%, marking a decrease of 1.00%.
- For Other Income, as of Jun 2025, the value is 11.00 Cr.. The value appears strong and on an upward trend. It has increased from 8.00 Cr. (Mar 2025) to 11.00 Cr., marking an increase of 3.00 Cr..
- For Interest, as of Jun 2025, the value is 5.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 5.00 Cr..
- For Depreciation, as of Jun 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 39.00 Cr. (Mar 2025) to 40.00 Cr., marking an increase of 1.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 66.00 Cr.. The value appears to be declining and may need further review. It has decreased from 75.00 Cr. (Mar 2025) to 66.00 Cr., marking a decrease of 9.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
- For Net Profit, as of Jun 2025, the value is 49.00 Cr.. The value appears to be declining and may need further review. It has decreased from 56.00 Cr. (Mar 2025) to 49.00 Cr., marking a decrease of 7.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.96. The value appears to be declining and may need further review. It has decreased from 2.26 (Mar 2025) to 1.96, marking a decrease of 0.30.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: August 23, 2025, 2:11 pm
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,180 | 1,441 | 1,668 | 1,631 | 1,941 | 2,292 | 2,410 | 2,359 | 2,653 | 2,783 | 2,914 | 2,790 | 2,696 |
| Expenses | 1,032 | 1,240 | 1,427 | 1,400 | 1,639 | 1,964 | 1,998 | 1,861 | 2,235 | 2,442 | 2,505 | 2,405 | 2,313 |
| Operating Profit | 148 | 201 | 241 | 231 | 302 | 328 | 413 | 498 | 418 | 341 | 409 | 385 | 383 |
| OPM % | 13% | 14% | 14% | 14% | 16% | 14% | 17% | 21% | 16% | 12% | 14% | 14% | 14% |
| Other Income | 2 | 0 | 7 | 14 | 4 | 12 | 8 | 22 | 23 | 16 | 29 | 27 | 33 |
| Interest | 23 | 18 | 23 | 15 | 9 | 9 | 19 | 19 | 17 | 22 | 21 | 24 | 21 |
| Depreciation | 31 | 40 | 47 | 51 | 54 | 62 | 109 | 110 | 114 | 125 | 147 | 158 | 159 |
| Profit before tax | 96 | 143 | 178 | 178 | 244 | 268 | 292 | 391 | 311 | 210 | 269 | 230 | 235 |
| Tax % | 31% | 28% | 32% | 33% | 34% | 35% | 22% | 25% | 25% | 26% | 26% | 26% | |
| Net Profit | 66 | 103 | 120 | 120 | 161 | 175 | 226 | 292 | 233 | 154 | 200 | 170 | 175 |
| EPS in Rs | 2.74 | 4.29 | 5.01 | 4.99 | 6.69 | 7.07 | 9.11 | 11.74 | 9.35 | 6.21 | 8.05 | 6.84 | 7.03 |
| Dividend Payout % | 5% | 6% | 6% | 10% | 11% | 13% | 14% | 21% | 27% | 40% | 37% | 44% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 56.06% | 16.50% | 0.00% | 34.17% | 8.70% | 29.14% | 29.20% | -20.21% | -33.91% | 29.87% | -15.00% |
| Change in YoY Net Profit Growth (%) | 0.00% | -39.56% | -16.50% | 34.17% | -25.47% | 20.45% | 0.06% | -49.41% | -13.70% | 63.78% | -44.87% |
Relaxo Footwears Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 7% |
| 5 Years: | 3% |
| 3 Years: | 2% |
| TTM: | -8% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | -6% |
| 3 Years: | -10% |
| TTM: | -7% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | -5% |
| 3 Years: | -21% |
| 1 Year: | -39% |
| Return on Equity | |
|---|---|
| 10 Years: | 15% |
| 5 Years: | 12% |
| 3 Years: | 9% |
| Last Year: | 8% |
Last Updated: September 5, 2025, 1:05 pm
Balance Sheet
Last Updated: December 4, 2025, 1:53 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 6 | 6 | 12 | 12 | 12 | 12 | 25 | 25 | 25 | 25 | 25 | 25 | 25 |
| Reserves | 271 | 362 | 468 | 594 | 749 | 1,093 | 1,248 | 1,548 | 1,735 | 1,830 | 1,976 | 2,073 | 2,085 |
| Borrowings | 198 | 239 | 236 | 178 | 153 | 112 | 139 | 144 | 174 | 164 | 205 | 213 | 215 |
| Other Liabilities | 182 | 234 | 281 | 286 | 335 | 394 | 430 | 459 | 448 | 476 | 508 | 452 | 545 |
| Total Liabilities | 657 | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,176 | 2,383 | 2,495 | 2,714 | 2,762 | 2,870 |
| Fixed Assets | 366 | 472 | 531 | 541 | 525 | 848 | 981 | 938 | 987 | 1,150 | 1,371 | 1,344 | 1,336 |
| CWIP | 24 | 2 | 28 | 62 | 138 | 11 | 46 | 118 | 149 | 89 | 33 | 54 | 75 |
| Investments | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 338 | 194 | 225 | 108 | 343 | 422 |
| Other Assets | 267 | 367 | 438 | 466 | 587 | 752 | 814 | 782 | 1,052 | 1,030 | 1,202 | 1,021 | 1,037 |
| Total Assets | 657 | 841 | 997 | 1,070 | 1,250 | 1,611 | 1,841 | 2,176 | 2,383 | 2,495 | 2,714 | 2,762 | 2,870 |
Below is a detailed analysis of the balance sheet data for Relaxo Footwears Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 25.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 25.00 Cr..
- For Reserves, as of Sep 2025, the value is 2,085.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,073.00 Cr. (Mar 2025) to 2,085.00 Cr., marking an increase of 12.00 Cr..
- For Borrowings, as of Sep 2025, the value is 215.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 213.00 Cr. (Mar 2025) to 215.00 Cr., marking an increase of 2.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 545.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 452.00 Cr. (Mar 2025) to 545.00 Cr., marking an increase of 93.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 2,870.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2,762.00 Cr. (Mar 2025) to 2,870.00 Cr., marking an increase of 108.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,336.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,344.00 Cr. (Mar 2025) to 1,336.00 Cr., marking a decrease of 8.00 Cr..
- For CWIP, as of Sep 2025, the value is 75.00 Cr.. The value appears strong and on an upward trend. It has increased from 54.00 Cr. (Mar 2025) to 75.00 Cr., marking an increase of 21.00 Cr..
- For Investments, as of Sep 2025, the value is 422.00 Cr.. The value appears strong and on an upward trend. It has increased from 343.00 Cr. (Mar 2025) to 422.00 Cr., marking an increase of 79.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,037.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,021.00 Cr. (Mar 2025) to 1,037.00 Cr., marking an increase of 16.00 Cr..
- For Total Assets, as of Sep 2025, the value is 2,870.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,762.00 Cr. (Mar 2025) to 2,870.00 Cr., marking an increase of 108.00 Cr..
Notably, the Reserves (2,085.00 Cr.) exceed the Borrowings (215.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -50.00 | -38.00 | 5.00 | 53.00 | 149.00 | 216.00 | 274.00 | 354.00 | 244.00 | 177.00 | 204.00 | 172.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 21 | 21 | 24 | 28 | 33 | 35 | 26 | 28 | 34 | 35 | 45 | 41 |
| Inventory Days | 109 | 163 | 147 | 146 | 130 | 130 | 157 | 154 | 202 | 154 | 179 | 177 |
| Days Payable | 39 | 61 | 63 | 63 | 72 | 58 | 65 | 81 | 67 | 69 | 76 | 63 |
| Cash Conversion Cycle | 91 | 123 | 108 | 110 | 90 | 107 | 119 | 101 | 170 | 121 | 148 | 155 |
| Working Capital Days | 5 | 14 | 12 | 19 | 27 | 42 | 57 | 44 | 75 | 59 | 68 | 62 |
| ROCE % | 26% | 30% | 30% | 26% | 30% | 26% | 24% | 26% | 18% | 12% | 14% | 11% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 11,800,000 | 1.39 | 514.66 | 1,800,000 | 2025-12-08 01:55:51 | 555.56% |
| SBI Large & Midcap Fund | 4,049,449 | 0.5 | 176.62 | 1,550,000 | 2025-12-08 01:55:51 | 161.25% |
| SBI Equity Hybrid Fund | 2,533,988 | 0.13 | 110.52 | 2,533,988 | 2025-04-22 15:16:47 | 0% |
| SBI Magnum Childrens Benefit Fund - Investment Plan | 1,812,156 | 1.67 | 79.04 | 400,000 | 2025-12-08 01:55:51 | 353.04% |
| SBI Multicap Fund | 1,621,704 | 0.29 | 70.73 | 1,621,704 | 2025-04-22 15:56:54 | 0% |
| SBI Flexicap Fund | 1,347,099 | 0.25 | 58.75 | N/A | N/A | N/A |
| ICICI Prudential Bharat Consumption Fund | 307,585 | 0.41 | 13.42 | N/A | N/A | N/A |
| SBI Consumption Opportunities Fund | 290,000 | 0.39 | 12.65 | N/A | N/A | N/A |
| ICICI Prudential FMCG Fund | 221,692 | 0.5 | 9.67 | N/A | N/A | N/A |
| SBI Long Term Advantage Fund - Series VI | 90,000 | 1.44 | 3.93 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 6.84 | 8.05 | 6.21 | 9.36 | 11.74 |
| Diluted EPS (Rs.) | 6.84 | 8.05 | 6.21 | 9.35 | 11.74 |
| Cash EPS (Rs.) | 13.21 | 13.98 | 11.23 | 13.91 | 16.17 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 84.29 | 80.40 | 74.53 | 70.72 | 63.30 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 84.29 | 80.40 | 74.53 | 70.72 | 63.30 |
| Dividend / Share (Rs.) | 3.00 | 3.00 | 2.50 | 2.50 | 2.50 |
| Revenue From Operations / Share (Rs.) | 112.08 | 117.08 | 111.80 | 106.60 | 94.97 |
| PBDIT / Share (Rs.) | 16.43 | 17.49 | 14.24 | 17.66 | 20.86 |
| PBIT / Share (Rs.) | 10.07 | 11.57 | 9.21 | 13.09 | 16.43 |
| PBT / Share (Rs.) | 9.24 | 10.82 | 8.44 | 12.48 | 15.75 |
| Net Profit / Share (Rs.) | 6.84 | 8.05 | 6.21 | 9.35 | 11.74 |
| PBDIT Margin (%) | 14.66 | 14.94 | 12.73 | 16.56 | 21.96 |
| PBIT Margin (%) | 8.98 | 9.88 | 8.23 | 12.28 | 17.30 |
| PBT Margin (%) | 8.24 | 9.24 | 7.54 | 11.70 | 16.58 |
| Net Profit Margin (%) | 6.10 | 6.87 | 5.55 | 8.76 | 12.35 |
| Return on Networth / Equity (%) | 8.11 | 10.01 | 8.32 | 13.21 | 18.54 |
| Return on Capital Employeed (%) | 10.83 | 13.12 | 11.32 | 16.96 | 23.64 |
| Return On Assets (%) | 6.16 | 7.38 | 6.19 | 9.76 | 13.40 |
| Total Debt / Equity (X) | 0.00 | 0.01 | 0.00 | 0.01 | 0.00 |
| Asset Turnover Ratio (%) | 1.02 | 1.12 | 1.14 | 1.16 | 1.17 |
| Current Ratio (X) | 2.74 | 2.40 | 2.54 | 2.57 | 2.40 |
| Quick Ratio (X) | 1.50 | 1.25 | 1.34 | 1.11 | 1.46 |
| Inventory Turnover Ratio (X) | 4.82 | 1.99 | 1.91 | 2.39 | 1.99 |
| Dividend Payout Ratio (NP) (%) | 43.84 | 31.04 | 40.28 | 26.69 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 22.71 | 17.88 | 22.25 | 17.93 | 0.00 |
| Earning Retention Ratio (%) | 56.16 | 68.96 | 59.72 | 73.31 | 0.00 |
| Cash Earning Retention Ratio (%) | 77.29 | 82.12 | 77.75 | 82.07 | 0.00 |
| Interest Coverage Ratio (X) | 19.79 | 23.30 | 18.42 | 28.67 | 30.34 |
| Interest Coverage Ratio (Post Tax) (X) | 9.24 | 11.73 | 9.03 | 16.18 | 18.07 |
| Enterprise Value (Cr.) | 10084.44 | 20231.08 | 21055.11 | 26520.33 | 21706.20 |
| EV / Net Operating Revenue (X) | 3.61 | 6.94 | 7.57 | 10.00 | 9.20 |
| EV / EBITDA (X) | 24.66 | 46.46 | 59.42 | 60.35 | 41.88 |
| MarketCap / Net Operating Revenue (X) | 3.63 | 6.97 | 7.59 | 9.99 | 9.20 |
| Retention Ratios (%) | 56.15 | 68.95 | 59.71 | 73.30 | 0.00 |
| Price / BV (X) | 4.83 | 10.15 | 11.39 | 15.06 | 13.81 |
| Price / Net Operating Revenue (X) | 3.63 | 6.97 | 7.59 | 9.99 | 9.20 |
| EarningsYield | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
After reviewing the key financial ratios for Relaxo Footwears Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For Diluted EPS (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For Cash EPS (Rs.), as of Mar 25, the value is 13.21. This value is within the healthy range. It has decreased from 13.98 (Mar 24) to 13.21, marking a decrease of 0.77.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 84.29. It has increased from 80.40 (Mar 24) to 84.29, marking an increase of 3.89.
- For Dividend / Share (Rs.), as of Mar 25, the value is 3.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 3.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 112.08. It has decreased from 117.08 (Mar 24) to 112.08, marking a decrease of 5.00.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 16.43. This value is within the healthy range. It has decreased from 17.49 (Mar 24) to 16.43, marking a decrease of 1.06.
- For PBIT / Share (Rs.), as of Mar 25, the value is 10.07. This value is within the healthy range. It has decreased from 11.57 (Mar 24) to 10.07, marking a decrease of 1.50.
- For PBT / Share (Rs.), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 10.82 (Mar 24) to 9.24, marking a decrease of 1.58.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 6.84. This value is within the healthy range. It has decreased from 8.05 (Mar 24) to 6.84, marking a decrease of 1.21.
- For PBDIT Margin (%), as of Mar 25, the value is 14.66. This value is within the healthy range. It has decreased from 14.94 (Mar 24) to 14.66, marking a decrease of 0.28.
- For PBIT Margin (%), as of Mar 25, the value is 8.98. This value is below the healthy minimum of 10. It has decreased from 9.88 (Mar 24) to 8.98, marking a decrease of 0.90.
- For PBT Margin (%), as of Mar 25, the value is 8.24. This value is below the healthy minimum of 10. It has decreased from 9.24 (Mar 24) to 8.24, marking a decrease of 1.00.
- For Net Profit Margin (%), as of Mar 25, the value is 6.10. This value is within the healthy range. It has decreased from 6.87 (Mar 24) to 6.10, marking a decrease of 0.77.
- For Return on Networth / Equity (%), as of Mar 25, the value is 8.11. This value is below the healthy minimum of 15. It has decreased from 10.01 (Mar 24) to 8.11, marking a decrease of 1.90.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.83. This value is within the healthy range. It has decreased from 13.12 (Mar 24) to 10.83, marking a decrease of 2.29.
- For Return On Assets (%), as of Mar 25, the value is 6.16. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 6.16, marking a decrease of 1.22.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.00. This value is within the healthy range. It has decreased from 0.01 (Mar 24) to 0.00, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.02. It has decreased from 1.12 (Mar 24) to 1.02, marking a decrease of 0.10.
- For Current Ratio (X), as of Mar 25, the value is 2.74. This value is within the healthy range. It has increased from 2.40 (Mar 24) to 2.74, marking an increase of 0.34.
- For Quick Ratio (X), as of Mar 25, the value is 1.50. This value is within the healthy range. It has increased from 1.25 (Mar 24) to 1.50, marking an increase of 0.25.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 4.82. This value is within the healthy range. It has increased from 1.99 (Mar 24) to 4.82, marking an increase of 2.83.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 43.84. This value is within the healthy range. It has increased from 31.04 (Mar 24) to 43.84, marking an increase of 12.80.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 22.71. This value is within the healthy range. It has increased from 17.88 (Mar 24) to 22.71, marking an increase of 4.83.
- For Earning Retention Ratio (%), as of Mar 25, the value is 56.16. This value is within the healthy range. It has decreased from 68.96 (Mar 24) to 56.16, marking a decrease of 12.80.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 77.29. This value exceeds the healthy maximum of 70. It has decreased from 82.12 (Mar 24) to 77.29, marking a decrease of 4.83.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 19.79. This value is within the healthy range. It has decreased from 23.30 (Mar 24) to 19.79, marking a decrease of 3.51.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.24. This value is within the healthy range. It has decreased from 11.73 (Mar 24) to 9.24, marking a decrease of 2.49.
- For Enterprise Value (Cr.), as of Mar 25, the value is 10,084.44. It has decreased from 20,231.08 (Mar 24) to 10,084.44, marking a decrease of 10,146.64.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.61. This value exceeds the healthy maximum of 3. It has decreased from 6.94 (Mar 24) to 3.61, marking a decrease of 3.33.
- For EV / EBITDA (X), as of Mar 25, the value is 24.66. This value exceeds the healthy maximum of 15. It has decreased from 46.46 (Mar 24) to 24.66, marking a decrease of 21.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
- For Retention Ratios (%), as of Mar 25, the value is 56.15. This value is within the healthy range. It has decreased from 68.95 (Mar 24) to 56.15, marking a decrease of 12.80.
- For Price / BV (X), as of Mar 25, the value is 4.83. This value exceeds the healthy maximum of 3. It has decreased from 10.15 (Mar 24) to 4.83, marking a decrease of 5.32.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.63. This value exceeds the healthy maximum of 3. It has decreased from 6.97 (Mar 24) to 3.63, marking a decrease of 3.34.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Relaxo Footwears Ltd:
- Net Profit Margin: 6.1%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.83% (Industry Average ROCE: 11.71%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 8.11% (Industry Average ROE: 8.72%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.24
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 1.5
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 57.8 (Industry average Stock P/E: 47.48)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 6.1%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Footwears | Aggarwal City Square, Plot No. 10, Manglam Place, Delhi Delhi 110085 | rfl@relaxofootwear.com http://www.relaxofootwear.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ramesh Kumar Dua | Chairman & Managing Director |
| Mr. Mukand Lal Dua | Whole Time Director |
| Mr. Nikhil Dua | Whole Time Director |
| Mr. Gaurav Dua | Whole Time Director |
| Mr. Sushil Batra | Executive Director |
| Mr. Kuldip Singh Dhingra | Independent Director |
| Mr. Rajeev Rupendra Bhadauria | Independent Director |
| Ms. Richa Arora | Independent Director |
| Mr. Yogesh Kapur | Independent Director |
| Mr. Raj Kumar Jain | Independent Director |
FAQ
What is the intrinsic value of Relaxo Footwears Ltd?
Relaxo Footwears Ltd's intrinsic value (as of 13 December 2025) is 327.87 which is 19.04% lower the current market price of 405.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 10,083 Cr. market cap, FY2025-2026 high/low of 665/375, reserves of ₹2,085 Cr, and liabilities of 2,870 Cr.
What is the Market Cap of Relaxo Footwears Ltd?
The Market Cap of Relaxo Footwears Ltd is 10,083 Cr..
What is the current Stock Price of Relaxo Footwears Ltd as on 13 December 2025?
The current stock price of Relaxo Footwears Ltd as on 13 December 2025 is 405.
What is the High / Low of Relaxo Footwears Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Relaxo Footwears Ltd stocks is 665/375.
What is the Stock P/E of Relaxo Footwears Ltd?
The Stock P/E of Relaxo Footwears Ltd is 57.8.
What is the Book Value of Relaxo Footwears Ltd?
The Book Value of Relaxo Footwears Ltd is 84.7.
What is the Dividend Yield of Relaxo Footwears Ltd?
The Dividend Yield of Relaxo Footwears Ltd is 0.74 %.
What is the ROCE of Relaxo Footwears Ltd?
The ROCE of Relaxo Footwears Ltd is 11.2 %.
What is the ROE of Relaxo Footwears Ltd?
The ROE of Relaxo Footwears Ltd is 8.31 %.
What is the Face Value of Relaxo Footwears Ltd?
The Face Value of Relaxo Footwears Ltd is 1.00.